BamSEC and AlphaSense Join Forces
Learn More

Voyager Acquisition Corp./Cayman Islands – Material Contracts

Formerly NASDAQ: VACHU

Material Contracts Filter

EX-10.22
from F-4/A 4 pages First Amendment to Voting, Support and Lock-Up Agreement
12/34/56
EX-10.1
from 8-K 3 pages First Amendment to Sponsor Support Agreement
12/34/56
EX-10.1
from 425 3 pages First Amendment to Sponsor Support Agreement
12/34/56
EX-10.21
from F-4/A 34 pages Certain Information in This Document, Marked by [***], Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10)(iv). Such Excluded Information Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. License Agreement Between Veraxa Biotech Gmbh and Cherry Biolabs Gmbh Contents
12/34/56
EX-10.20
from F-4/A 62 pages Share Contribution Agreement Synimmune Gmbh Document Register No. 3009/2023 AG of Hamburg Notary Dr. Alexander Gebele
12/34/56
EX-10.19
from F-4/A 14 pages December 13, 2017 Patent, Know-How, and Software License Agreement
12/34/56
EX-10.16
from F-4/A 4 pages Agreement on the Lending of Securities (Securities Lending Agreement) Between
12/34/56
EX-10.15
from F-4/A 5 pages Service Level Agreement Between Veraxa Biotech AG Talacker 35, Ch-8001 Zurich, Switzerland - Hereinafter Referred to as “Veraxa” - And Xlife Sciences AG Talacker 35, Ch-8001 Zurich, Switzerland - Hereinafter Referred to as “Xlife” - Veraxa and Xlife Are Hereinafter Also Referred to Collectively as the “Parties”
12/34/56
EX-10.14
from F-4/A 16 pages Shareholders’ Agreement Between
12/34/56
EX-10.18
from F-4 15 pages Sponsor Support Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”), Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), and Voyager Acquisition Sponsor Holdco LLC, a Delaware Limited Liability Company (“Sponsor”)
12/34/56
EX-10.17
from F-4 13 pages Voting, Support and Lock-Up Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”) and the Persons Listed on Schedule a Hereto (Each, a “Shareholder” and Collectively, the “Shareholders”)
12/34/56
EX-10.18
from F-4 15 pages Sponsor Support Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”), Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), and Voyager Acquisition Sponsor Holdco LLC, a Delaware Limited Liability Company (“Sponsor”)
12/34/56
EX-10.17
from F-4 13 pages Voting, Support and Lock-Up Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”) and the Persons Listed on Schedule a Hereto (Each, a “Shareholder” and Collectively, the “Shareholders”)
12/34/56
EX-10.1
from 8-K 9 pages Joinder Agreement
12/34/56
EX-10.1
from 425 9 pages Joinder Agreement
12/34/56
EX-10.2
from 425 15 pages Sponsor Support Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”), Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), and Voyager Acquisition Sponsor Holdco LLC, a Delaware Limited Liability Company (“Sponsor”)
12/34/56
EX-10.2
from 8-K 15 pages Sponsor Support Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”), Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), and Voyager Acquisition Sponsor Holdco LLC, a Delaware Limited Liability Company (“Sponsor”)
12/34/56
EX-10.1
from 425 13 pages Voting, Support and Lock-Up Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”) and the Persons Listed on Schedule a Hereto (Each, a “Shareholder” and Collectively, the “Shareholders”)
12/34/56
EX-10.1
from 8-K 13 pages Voting, Support and Lock-Up Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”) and the Persons Listed on Schedule a Hereto (Each, a “Shareholder” and Collectively, the “Shareholders”)
12/34/56
EX-10.7
from 8-K 6 pages Advisor Agreement
12/34/56